A phase I dose escalation and pharmacokinetic trial of intra-vesical gemcitabine in the treatment of recurrent superficial transitional cell carcinoma of the bladder

By Maddineni S.   Sangar V.   King H.   Betts C.   O'Flynn K.   Lupton E.   George N.   Ramani V.   Clarke N.  

European Urology Supplements, Vol. 2, Iss. 1, 2003-02 ,pp. : 192-192

Elsevier

Access to resources Recommend Favorite

Transitional Cell Carcinoma of the Bladder in Children

By Serrano-Durbá Agustín   Dominguez-Hinarejos Carlos   Reig-Ruiz Carlos   Fernandez-Córdoba Marisol   Garcia-Ibarra Fernando  

Scandinavian Journal of Urology and Nephrology, Vol. 33, Iss. 1, 1999-02 ,pp. : 73-76

Informa Healthcare

Access to resources Recommend Favorite

Upper-tract transitional cell carcinoma

By Tawfiek E.R.   Bagley D.H.  

Urology, Vol. 50, Iss. 3, 1997-09 ,pp. : 321-329

Elsevier

Access to resources Recommend Favorite

Biomarkers for transitional cell carcinoma-pro

By Grossman H.B.  

Urology, Vol. 57, Iss. 5, 2001-05 ,pp. : 847-848

Elsevier

Access to resources Recommend Favorite

Biomarkers for transitional cell carcinoma-con

By Schoenberg M.  

Urology, Vol. 57, Iss. 5, 2001-05 ,pp. : 849-851

Elsevier

Access to resources Recommend Favorite